Aspen Surgical Products Receives Additional Investment from Audax Private Equity

Aspen Surgical Products CEO Jason Krieser said, "This transaction represents an excellent return for our original investors, while empowering our Aspen Surgical organization to continue to progress in our mission of improving safety and efficiency for clinicians at an even faster rate.”

Aspen Surgical Products (“Aspen”), a portfolio company of Audax Private Equity (“Audax”), announced today that Audax has closed on a single-asset continuation fund to support additional investment in Aspen and reaffirming its commitment to supporting the company’s long-term growth strategy.

Since Audax’s original investment in 2019, Aspen has tripled the scale of the company by acquiring five complementary businesses, further developing and diversifying its sales channel, and accelerating innovative product line extensions. This new investment will allow Audax to continue to support the Aspen executive leadership team as it pursues imminent organic growth and larger-scale acquisition opportunities in order to

“A little over two years ago we embarked on a journey to dramatically enhance our value with our hospital customers and channel partners,” said Jason Krieser, CEO of Aspen. “I couldn’t be happier with our success to date. This transaction represents an excellent return for our original investors, while empowering our Aspen Surgical organization to continue to progress in our mission of improving safety and efficiency for clinicians at an even faster rate.”

More

Cofertility Closes Series A Funding, Led by Next Ventures and Offline Ventures, to Revolutionize Fertility and Family Building

The funding will be primarily used towards the further development of Cofertility’s proprietary, user-friendly technology platform, a custom-built egg donor database that streamlines the entire egg donation process, from recruitment and matching to cycle coordination. Already this technology has helped improve the Cofertility experience for its members.